Return of the Investigational Product Vrácení Hodnoceného léčiva Sample Clauses

Return of the Investigational Product Vrácení Hodnoceného léčiva. 7.4.1 The Investigator shall return all unused Investigational Product, as well as any containers, whether containing unused Investigational Product or not, in accordance with the instructions of Sponsor or CRO upon expiration or termination of the Study or at such times as CRO or Sponsor may direct at Sponsor’s expense. Po dokončení nebo ukončení Klinického hodnocení nebo kdykoliv, kdy to Zadavatel nebo CRO nařídí, Zkoušející vrátí veškerá nepoužitá Hodnocená léčiva jakož i jakákoliv balení, ať už obsahují nepoužité Hodnocené léčivo či nikoliv, v souladu s pokyny Zadavatele nebo společnosti CRO na náklady Zadavatele.
Sample 1
AutoNDA by SimpleDocs
Return of the Investigational Product Vrácení Hodnoceného léčiva. 7.4.1 The Institution shall ensure that the Investigator shall return all unused Investigational Product, as well as any containers, whether containing unused Investigational Product or not, in accordance with the instructions of the Sponsor or ICON upon termination of the Study or at such times as the Sponsor or ICON may direct. Alternatively, Institution or Institution’s authorized designee, at ICON/Sponsor’s direction, shall destroy all unused Investigational Product, as well as any containers, whether containing unused Investigational Product or not, and shall provide written certification of such destruction to Sponsor and ICON. Zdravotnické zařízení zajistí, že po ukončení klinického hodnocení nebo kdykoliv, kdy to zadavatel nebo ICON nařídí, zkoušející vrátí veškerá nepoužitá hodnocená léčiva jakož i jakákoliv balení, ať už obsahují nepoužité hodnocené léčivo či nikoliv, v souladu s pokyny zadavatele nebo společnosti ICON. Nebo zdravotnické zařízení xxxx xxx pověřená osoba na pokyn společnosti ICON/zadavatele zničí veškeré nepoužité hodnocené léčivo i veškerá balení bez ohledu na to, zda obsahují hodnocené léčivo či nikoli, a poskytnou o takovém zničení zadavateli a společnosti ICON písemné potvrzení.
Sample 1
Return of the Investigational Product Vrácení Hodnoceného léčiva. 7.4.1 The Institution’s pharmacy shall return all unused Investigational Product in accordance with the instructions of Sponsor or CRO upon expiration or termination of the Study or at such times as CRO or Sponsor may direct. Po dokončení nebo ukončení Klinického hodnocení nebo kdykoliv, kdy to Zadavatel nebo CRO nařídí, lékárna Poskytovatele vrátí veškerá nepoužitá Hodnocená léčiva v souladu s pokyny Zadavatele nebo společnosti CRO.
Sample 1
Return of the Investigational Product Vrácení Hodnoceného léčiva. 7.4.1 The Investigator shall return all unused Investigational Product, as well as any containers, whether containing unused Investigational Product or not, in accordance with the instructions of Sponsor or CRO upon expiration or termination of the Study or at such times as CRO or Sponsor may direct. Po dokončení nebo ukončení Klinického hodnocení nebo kdykoliv, kdy to Zadavatel nebo CRO nařídí, Zkoušející vrátí veškerá nepoužitá Hodnocená léčiva jakož i jakákoliv balení, ať už obsahují nepoužité Hodnocené léčivo či nikoliv, v souladu s pokyny Zadavatele nebo společnosti CRO. 8
Sample 1
Return of the Investigational Product Vrácení Hodnoceného léčiva. 7.4.1 The Investigator shall return all unused Investigational Product, as well as any containers, whether containing unused Investigational Product or not, in accordance with the instructions of the Sponsor or ICON upon expiration or termination of the Study or at such times as the Sponsor or ICON may direct. Po dokončení nebo ukončení Klinického hodnocení nebo kdykoliv, kdy to Zadavatel nebo ICON nařídí, Zkoušející vrátí veškerá nepoužitá Hodnocená léčiva jakož i jakákoliv balení, ať už obsahují nepoužité Hodnocené léčivo či nikoliv, v souladu s pokyny Zadavatele nebo společnosti ICON.
Sample 1

Related to Return of the Investigational Product Vrácení Hodnoceného léčiva

  • Search, Enquiry, Investigation, Examination And Verification a. The Property is sold on an “as is where is basis” subject to all the necessary inspection, search (including but not limited to the status of title), enquiry (including but not limited to the terms of consent to transfer and/or assignment and outstanding charges), investigation, examination and verification of which the Purchaser is already advised to conduct prior to the auction and which the Purchaser warrants to the Assignee has been conducted by the Purchaser’s independent legal advisors at the time of execution of the Memorandum.

  • Geotechnical Investigation Perform in accordance with the City Design Manual and other City requirements as designated in writing by the Director.

  • Complaints Investigation An employee who complains of harassment under the provisions of the Human Rights Code of British Columbia may refer the complaint to either one or other of the following processes:

  • BACKGROUND INVESTIGATION The BOARD is prohibited from knowingly employing a person who has been convicted of committing or attempting to commit certain criminal offenses. If the required criminal background investigation is not completed at the time this Contract is signed, and the subsequent investigation report reveals that there has been a prohibited conviction, this Contract shall immediately become null and void.

  • Technical Standards Applicable to a Wind Generating Plant i. Low Voltage Ride-Through (LVRT) Capability A wind generating plant shall be able to remain online during voltage disturbances up to the time periods and associated voltage levels set forth in the standard below. The LVRT standard provides for a transition period standard and a post-transition period standard.

  • Background Investigations OSC policy requires that background investigations be conducted on Contractor Staff who will have access to OSC’s IT systems, access to OSC confidential information/data, or routine access to any OSC facility. For purposes of this policy, “routine access” is defined as access to an OSC facility for five consecutive business days or 10 business days over the annual term of the engagement. Accordingly, with the signing of this Agreement, the Contractor certifies that it has or will conduct a background investigation on Staff to whom the policy applies within the 12 months prior to the Staff commencing Services under this Agreement. The Contractor agrees to undertake a background investigation of any new/replacement Staff during the term of the Agreement. At a minimum, background investigations shall include a review/evaluation of the following: • identity verification, including Social Security Number search; • employment eligibility, including verification of U.S. citizenship or legal immigration status where appropriate; • criminal history/court records (Federal, State and local for the past five years); • work experience/history for the past five years; • pertinent skills, qualifications, and education/professional credentials; and • references. The Contractor must obtain the consent of its Staff to allow OSC, upon request: (i) to review the background investigation records, including all supporting documentation, and (ii) to conduct its own background investigation. Only Staff who have passed the background investigation, and provided such consent shall be assigned to provide Services to OSC under this Agreement. During the term of the Agreement, and in accordance with Appendix A (Section 10, Records), the Contractor must maintain records related to the background investigations performed.

  • Xxxxxx and Recall An employee in receipt of notice of layoff pursuant to 9.08(A)(a)(ii) may:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!